G
Giuseppe Mancia
Researcher at University of Milano-Bicocca
Publications - 1465
Citations - 152794
Giuseppe Mancia is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 145, co-authored 1369 publications receiving 139692 citations. Previous affiliations of Giuseppe Mancia include University of Milan & Instituto Politécnico Nacional.
Papers
More filters
Journal ArticleDOI
Variability in arterial diameter and compliance: compliance modulation reserve.
TL;DR: In hypertensive subjects radial artery compliance can be markedly increased on a acute basis, indicating that those antihypertensive drugs that improve compliance have a considerable reserve to act upon.
Journal ArticleDOI
Increased pulse wave velocity and not reduced ejection fraction is associated with impaired baroreflex control of heart rate in congestive heart failure.
Alberto Radaelli,Paolo Castiglioni,Giulia Balestri,Francesca Cesana,Caterina De Carlini,Francesco Soriano,Arianna Azzellino,Marco Di Rienzo,Giovanni Paolini,Alberto U. Ferrari,Giuseppe Mancia +10 more
TL;DR: In CHF and CAD patients, the baroreflex impairment correlates significantly with the increased PWV and not with ejection fraction, and is similar to that of CAD patients without MI.
Journal ArticleDOI
Commentary on the revised british hypertension society protocol for evaluation of blood pressure measuring devices: A critique of aspects related to 24-hour ambulatory blood pressure measurement
Journal ArticleDOI
Reduction in estimated stroke risk associated with practice-based stroke-risk assessment and awareness in a large, representative population of hypertensive patients: results from the ForLife study in Italy.
Massimo Volpe,Enrico Agabiti Rosei,Ettore Ambrosioni,Gastone Leonetti,Bruno Trimarco,Giuseppe Mancia +5 more
TL;DR: This large-scale observational study demonstrates that the assessment of stroke risk and increased awareness of strokes risk factors by GPs is associated with improved blood pressure control, reduced cardiovascular risk profile and a prompt reduction in the 10-year estimated risk of stroke.
Journal ArticleDOI
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results
Sverre E. Kjeldsen,Domenic A. Sica,Hermann Haller,Gloria Cha,Blas Gil-Extremera,Peter Harvey,Frank Heyvaert,Andrew J. Lewin,G. Villa,Giuseppe Mancia +9 more
TL;DR: N/C combination was effective in participants with hypertension and showed an improved side effect profile compared with N monotherapy, and combination therapy was similarly effective in different racial groups.